YEAR-END REPORT JANUARY-DECEMBER 2014
Summary: fourth quarter 2014 · Net sales improved marginally compared with the fourth quarter of 2013, SEK 2,099k (2,056k). · Comprehensive income for the period was a loss of SEK 7,861k (loss: 5,313k). · Earnings per share totaled SEK -0.36 (-0.34). · Cash flow from operating activities was SEK -5,676k (-1,502k). · Genovis established US subsidiary Genovis Inc. · Genovis’ project for automatic analysis with the FabRICATOR enzyme showed proof-of-concept. · Genovis filed a plaint against Promega Corporation for patent infringement since IdeS Protease is